PravastatinKidneyHydroxymethylglutaryl-CoA Reductase InhibitorsAnticholesteremic AgentsHepatic ArteryKidney DiseasesKidney TransplantationHeptanoic AcidsHepatic VeinsLiverKidney TubulesHypercholesterolemiaSimvastatinKidney CortexPyrrolesAcute Kidney InjuryHepatic EncephalopathyCholesterolKidney Failure, ChronicHepatic Stellate CellsFosinoprilLovastatinCholesterol, LDLHepatocytesPolycystic Kidney DiseasesKidney NeoplasmsKidney GlomerulusLipidsFluorobenzenesKidney Function TestsKidney Tubules, ProximalRats, Sprague-DawleyLiver DiseasesLiver CirculationKidney MedullaFatty Acids, MonounsaturatedLiver NeoplasmsRNA, MessengerOrganic Anion TransportersTime FactorsTreatment OutcomeTriglyceridesMevalonic AcidLiver CirrhosisFatty LiverKidney CalculiRats, WistarDrug InteractionsDisease Models, AnimalDose-Response Relationship, DrugPhysiological ProcessesHydroxymethylglutaryl CoA ReductasesMice, Inbred C57BLPolycystic Kidney, Autosomal DominantKidney Tubules, CollectingDouble-Blind MethodHepatectomyGlomerular Filtration RateMicrosomes, LiverHyperlipidemiasAlanine TransaminaseOrganic Anion Transporters, Sodium-Independent